Document is current
Any future updates will be listed below
-
Authors
Ratnasiri, Kalani https://orcid.org/0000-0001-5953-0004
Wilk, Aaron J. https://orcid.org/0000-0003-1430-5852
Lee, Madeline J. https://orcid.org/0000-0001-5039-6806
Khatri, Purvesh https://orcid.org/0000-0002-4143-4708
Blish, Catherine A. https://orcid.org/0000-0001-6946-7627
-
Funding
Funding for this research was provided by:
NIH Office of the Director (DP1 DA045089)
Bill and Melinda Gates Foundation (OP113682)
Bill and Melinda Gates Foundation (OP113682)
NIH (U19AI109662)
NIH (T32 AI00729037)
NIH (T32 GM007364)
NIH (F31 AI172311)
Bio-X Graduate Fellowship
National Science Foundation (2019282939)
Department of Defense (W81WXH-18-1-0253)
Department of Defense (W91XWJ10235)
Dr. Ralph and Marian Falk Medical Research Trust
Chan Zuckerberg Biohub
- License Information
-
More Information
Article History
Received: 16 August 2022
Accepted: 31 October 2022
First Online: 21 November 2022
Declarations
:
: PK is a shareholder in Inflammatix.
